Featured Articles
-
Understanding Adeno-Associated Virus Vector Impurities
11/13/2025
AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.
-
Cell Culture Media Demystified For Performance, Quality, And Innovation
11/13/2025
Cell culture media isn’t one-size-fits-all. Learn how media composition, customization, and analytics can dramatically improve cell growth, productivity, and product quality for complex processes.
-
Scale-Up Of A Transient rAAV Production Process
11/3/2025
Scalable rAAV production is achievable with a transient cell line and optimized bioreactor setup, delivering high titers and reduced impurities, now validated at 200 L scale for commercial readiness.
-
Scale-Up Of An Adherent rAAV Production Process
11/3/2025
Fixed-bed bioreactors simplify the scale-up of viral vector production. Discover a system that bridges development and manufacturing with data confirming consistent performance across scales.
-
A Simple Method For Cell Growth Media Preparation
11/3/2025
Explore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.
-
Exosome Production From hMSC Using A Fixed-Bed Bioreactor
11/3/2025
Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.
-
Research-Scale Oligonucleotide Workflow
10/30/2025
Get a clear view of oligonucleotide development from synthesis to purification and filtration with practical insights to help you streamline workflows and stay ahead in the fight against disease.
-
A Guide To Bioprocess Filters
10/1/2025
Discover a practical guide to selecting filters for bioprocessing applications that are matched to product type, process stage, and performance needs such as virus filtration, clarification, and TFF.
-
Speed Your Science With Integrated, End-To-End Manufacturing
10/1/2025
Explore how to simplify your downstream viral vector manufacturing with integrated, end-to-end strategies that reduce delays and accelerate your path to the clinic.
-
Rethink Cell Therapy With LNPs
8/25/2025
Explore how lipid nanoparticles are revolutionizing cell therapy workflows to enable the precise delivery of mRNA and gene editing tools for next-generation treatments like CAR T and HSC therapies.